Exhibit 99.2
MetLife, Inc.
GAAP Interim Condensed Consolidated Statements of Operations
(Unaudited)
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
(In millions) | (In millions) | |||||||||||||||
Revenues | ||||||||||||||||
Premiums | $ | 9,417 | $ | 9,312 | $ | 19,110 | $ | 18,565 | ||||||||
Universal life and investment-type product policy fees | 2,286 | 2,434 | 4,630 | 4,828 | ||||||||||||
Net investment income | 4,887 | 4,947 | 9,446 | 10,408 | ||||||||||||
Other revenues | 487 | 518 | 974 | 1,013 | ||||||||||||
Net investment gains (losses) | 266 | (133 | ) | 281 | 153 | |||||||||||
Net derivative gains (losses) | (2,099 | ) | (912 | ) | (764 | ) | (91 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Total revenues | 15,244 | 16,166 | 33,677 | 34,876 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Expenses | ||||||||||||||||
Policyholder benefits and claims | 10,274 | 9,352 | 19,952 | 18,609 | ||||||||||||
Interest credited to policyholder account balances | 1,500 | 1,298 | 2,826 | 3,293 | ||||||||||||
Policyholder dividends | 324 | 331 | 639 | 670 | ||||||||||||
Other expenses | 3,246 | 4,072 | 7,438 | 8,132 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total expenses | 15,344 | 15,053 | 30,855 | 30,704 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations before provision for income tax | (100 | ) | 1,113 | 2,822 | 4,172 | |||||||||||
Provision for income tax expense (benefit) | (214 | ) | (6 | ) | 505 | 890 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | 114 | 1,119 | 2,317 | 3,282 | ||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 4 | 4 | 6 | 9 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) attributable to MetLife, Inc. | 110 | 1,115 | 2,311 | 3,273 | ||||||||||||
Less: Preferred stock dividends | 46 | 31 | 52 | 61 | ||||||||||||
Preferred stock repurchase premium | — | 42 | — | 42 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 64 | $ | 1,042 | $ | 2,259 | $ | 3,170 | ||||||||
|
|
|
|
|
|
|
|
See footnotes on last page.
MetLife, Inc.
Consolidated Statements of Operating Earnings Available to Common Shareholders
(Unaudited)
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
(In millions) | (In millions) | |||||||||||||||
Operating revenues | ||||||||||||||||
Premiums | $ | 9,417 | $ | 9,313 | $ | 18,684 | $ | 18,566 | ||||||||
Universal life and investment-type product policy fees | 2,173 | 2,335 | 4,324 | 4,629 | ||||||||||||
Net investment income | 4,881 | 5,185 | 9,587 | 10,167 | ||||||||||||
Other revenues | 484 | 527 | 971 | 1,030 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total operating revenues | 16,955 | 17,360 | 33,566 | 34,392 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating expenses | ||||||||||||||||
Policyholder benefits and claims and policyholder dividends | 10,385 | 9,503 | 19,978 | 18,950 | ||||||||||||
Interest credited to policyholder account balances | 1,314 | 1,342 | 2,615 | 2,673 | ||||||||||||
Capitalization of DAC | (915 | ) | (927 | ) | (1,791 | ) | (1,895 | ) | ||||||||
Amortization of DAC and VOBA | 1,015 | 1,001 | 1,896 | 1,954 | ||||||||||||
Amortization of negative VOBA | (61 | ) | (83 | ) | (128 | ) | (173 | ) | ||||||||
Interest expense on debt | 303 | 307 | 615 | 604 | ||||||||||||
Other operating expenses | 3,659 | 3,882 | 7,369 | 7,682 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total operating expenses | 15,700 | 15,025 | 30,554 | 29,795 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings before provision for income tax | 1,255 | 2,335 | 3,012 | 4,597 | ||||||||||||
Provision for income tax expense (benefit) | 285 | 539 | 707 | 1,133 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings | 970 | 1,796 | 2,305 | 3,464 | ||||||||||||
Preferred stock dividends | 46 | 31 | 52 | 61 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | $ | 924 | $ | 1,765 | $ | 2,253 | $ | 3,403 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Reconciliation to Income (Loss) from Continuing Operations, Net of Income Tax | ||||||||||||||||
Operating earnings | $ | 970 | $ | 1,796 | $ | 2,305 | $ | 3,464 | ||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | ||||||||||||||||
Net investment gains (losses) (1) | 266 | (133 | ) | 281 | 153 | |||||||||||
Net derivative gains (losses) (1) | (2,099 | ) | (912 | ) | (764 | ) | (91 | ) | ||||||||
Premiums | — | (1 | ) | 426 | (1 | ) | ||||||||||
Universal life and investment-type product policy fees | 113 | 99 | 306 | 199 | ||||||||||||
Net investment income | 6 | (238 | ) | (141 | ) | 241 | ||||||||||
Other revenues | 3 | (9 | ) | 3 | (17 | ) | ||||||||||
Policyholder benefits and claims and policyholder dividends (1) | (213 | ) | (180 | ) | (613 | ) | (329 | ) | ||||||||
Interest credited to policyholder account balances | (186 | ) | 44 | (211 | ) | (620 | ) | |||||||||
Capitalization of DAC | — | — | 105 | — | ||||||||||||
Amortization of DAC and VOBA (1) | 894 | 104 | 780 | 32 | ||||||||||||
Amortization of negative VOBA | 6 | 9 | 38 | 19 | ||||||||||||
Interest expense on debt | (3 | ) | (1 | ) | (3 | ) | (2 | ) | ||||||||
Other operating expenses | (142 | ) | (4 | ) | (397 | ) | (9 | ) | ||||||||
Goodwill impairment | — | — | — | — | ||||||||||||
Provision for income tax (expense) benefit (1) | 499 | 545 | 202 | 243 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations, net of income tax | 114 | 1,119 | 2,317 | 3,282 | ||||||||||||
Income (loss) from discontinued operations, net of income tax | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | 114 | 1,119 | 2,317 | 3,282 | ||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 4 | 4 | 6 | 9 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) attributable to MetLife, Inc. | 110 | 1,115 | 2,311 | 3,273 | ||||||||||||
Less: Preferred stock dividends | 46 | 31 | 52 | 61 | ||||||||||||
Preferred stock repurchase premium | — | 42 | — | 42 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 64 | $ | 1,042 | $ | 2,259 | $ | 3,170 | ||||||||
|
|
|
|
|
|
|
|
See footnotes on last page.
MetLife, Inc.
(Unaudited)
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||||||||||||
Earnings Per Weighted Average Common Shares Diluted (2) | Earnings Per Weighted Average Common Shares Diluted (2) | Earnings Per Weighted Average Common Shares Diluted (2) | Earnings Per Weighted Average Common Shares Diluted (2) | |||||||||||||||||||||||||||||
(In millions, except per share data) | (In millions, except per share data) | |||||||||||||||||||||||||||||||
Reconciliation to Net Income (Loss) Available to MetLife, Inc.’s Common Shareholders | ||||||||||||||||||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 1,410 | $ | 1.27 | $ | 1,704 | $ | 1.51 | $ | 2,860 | $ | 2.58 | $ | 3,358 | $ | 2.97 | ||||||||||||||||
Add: Total notable items | (486 | ) | (0.44 | ) | 61 | 0.05 | (607 | ) | (0.55 | ) | 45 | 0.04 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||
Operating earnings available to common shareholders | $ | 924 | $ | 0.83 | $ | 1,765 | $ | 1.56 | $ | 2,253 | $ | 2.03 | $ | 3,403 | $ | 3.01 | ||||||||||||||||
Adjustments from operating earnings available to common shareholders to net income (loss) available to MetLife, Inc.’s common shareholders: | ||||||||||||||||||||||||||||||||
Add: Net investment gains (losses) | 266 | 0.24 | (133 | ) | (0.12 | ) | 281 | 0.25 | 153 | 0.14 | ||||||||||||||||||||||
Add: Net derivative gains (losses) | (2,099 | ) | (1.89 | ) | (912 | ) | (0.81 | ) | (764 | ) | (0.69 | ) | (91 | ) | (0.08 | ) | ||||||||||||||||
Add: Goodwill impairment | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Add: Other adjustments to continuing operations | 478 | 0.43 | (177 | ) | (0.15 | ) | 293 | 0.27 | (487 | ) | (0.43 | ) | ||||||||||||||||||||
Add: Provision for income tax (expense) benefit | 499 | 0.45 | 545 | 0.48 | 202 | 0.18 | 243 | 0.21 | ||||||||||||||||||||||||
Add: Income (loss) from discontinued operations, net of income tax | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 4 | — | 4 | — | 6 | — | 9 | 0.01 | ||||||||||||||||||||||||
Less: Preferred stock repurchase premium | — | — | 42 | 0.04 | — | — | 42 | 0.04 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 64 | $ | 0.06 | $ | 1,042 | $ | 0.92 | $ | 2,259 | $ | 2.04 | $ | 3,170 | $ | 2.80 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||
Weighted average common shares outstanding - diluted | 1,109.1 | 1,128.4 | 1,108.9 | 1,131.1 | ||||||||||||||||||||||||||||
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||||||||||||
(In millions) | (In millions) | |||||||||||||||||||||||||||||||
Reconciliation to Premiums, Fees and Other Revenues | ||||||||||||||||||||||||||||||||
Total operating premiums, fees and other revenues | $ | 12,074 | $ | 12,175 | $ | 23,979 | $ | 24,225 | ||||||||||||||||||||||||
Add: Adjustments to premiums, fees and other revenues | 116 | 89 | 735 | 181 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||||||
Total premiums, fees and other revenues | $ | 12,190 | $ | 12,264 | $ | 24,714 | $ | 24,406 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||||||
Reconciliation to Revenues and Expenses | ||||||||||||||||||||||||||||||||
Total operating revenues | $ | 16,955 | $ | 17,360 | $ | 33,566 | $ | 34,392 | ||||||||||||||||||||||||
Add: Net investment gains (losses) | 266 | (133 | ) | 281 | 153 | |||||||||||||||||||||||||||
Add: Net derivative gains (losses) | (2,099 | ) | (912 | ) | (764 | ) | (91 | ) | ||||||||||||||||||||||||
Add: Adjustments related to net investment gains (losses) and net derivative gains (losses) | 9 | 3 | 34 | 7 | ||||||||||||||||||||||||||||
Add: Other adjustments to revenues | 113 | (152 | ) | 560 | 415 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||||||
Total revenues | $ | 15,244 | $ | 16,166 | $ | 33,677 | $ | 34,876 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||||||
Total operating expenses | $ | 15,700 | $ | 15,025 | $ | 30,554 | $ | 29,795 | ||||||||||||||||||||||||
Add: Adjustments related to net investment gains (losses) and net derivative gains (losses) | (1,087 | ) | (94 | ) | (1,081 | ) | 1 | |||||||||||||||||||||||||
Add: Goodwill impairment | — | — | — | — | ||||||||||||||||||||||||||||
Add: Other adjustments to expenses | 731 | 122 | 1,382 | 908 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||||||
Total expenses | $ | 15,344 | $ | 15,053 | $ | 30,855 | $ | 30,704 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
See footnotes on last page.
MetLife, Inc.
(Unaudited)
June 30, | ||||||||
2016 | 2015 | |||||||
Book Value (3) | ||||||||
Book value per common share | $ | 70.18 | $ | 60.27 | ||||
Less: Net unrealized investment gains (losses), net of income tax | 18.78 | 11.52 | ||||||
Less: Defined benefit plans adjustment, net of income tax | (1.80 | ) | (1.98 | ) | ||||
|
|
|
| |||||
Book value per common share, excluding AOCI other than FCTA | $ | 53.20 | $ | 50.73 | ||||
Less: Goodwill, net of income tax | 8.79 | 8.51 | ||||||
Less: VODA and VOCRA, net of income tax | 0.43 | 0.49 | ||||||
|
|
|
| |||||
Book value per common share - tangible common stockholders’ equity | $ | 43.98 | $ | 41.73 | ||||
|
|
|
| |||||
Common shares outstanding, end of period (In millions) | 1,098.8 | 1,116.8 | ||||||
For the Three Months Ended June 30, | ||||||||
2016 | 2015 | |||||||
Return on Equity (4) | ||||||||
Return on MetLife, Inc.’s: | ||||||||
Common stockholders’ equity | 0.3 | % | 6.0 | % | ||||
Common stockholders’ equity, excluding AOCI other than FCTA | 0.4 | % | 7.4 | % | ||||
Tangible common stockholders’ equity | 0.6 | % | 9.1 | % | ||||
Operating return on MetLife, Inc.’s: | ||||||||
Common stockholders’ equity | 4.9 | % | 10.2 | % | ||||
Common stockholders’ equity, excluding AOCI other than FCTA | 6.3 | % | 12.5 | % | ||||
Common stockholders’ equity, excluding AOCI other than FCTA, adjusted for total notable items | 9.5 | % | 12.1 | % | ||||
Tangible common stockholders’ equity | 7.7 | % | 15.3 | % | ||||
Tangible common stockholders’ equity, adjusted for total notable items | 11.5 | % | 14.9 | % | ||||
Return on Allocated Equity: | ||||||||
Americas | (7.6 | )% | 10.4 | % | ||||
Asia | 27.9 | % | 19.6 | % | ||||
EMEA | 11.8 | % | 7.7 | % | ||||
Return on Allocated Tangible Equity: | ||||||||
Americas | (8.3 | )% | 11.7 | % | ||||
Asia | 48.0 | % | 33.7 | % | ||||
EMEA | 20.2 | % | 14.2 | % | ||||
Operating Return on Allocated Equity: | ||||||||
Americas | 8.6 | % | 14.8 | % | ||||
Asia | 9.4 | % | 14.8 | % | ||||
EMEA | 7.9 | % | 6.0 | % | ||||
Operating Return on Allocated Tangible Equity: | ||||||||
Americas | 9.6 | % | 16.6 | % | ||||
Asia | 16.2 | % | 25.4 | % | ||||
EMEA | 13.8 | % | 11.2 | % |
See footnotes on last page.
MetLife, Inc.
Supplemental Reconciliations to Net Income (Loss) Available to Common Shareholders
(Unaudited)
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
(In millions) | (In millions) | |||||||||||||||
Total Americas Operations: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 1,266 | $ | 1,443 | $ | 2,520 | $ | 2,840 | ||||||||
Add: Total notable items | (431 | ) | — | (547 | ) | (16 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 835 | 1,443 | 1,973 | 2,824 | ||||||||||||
Add: Net investment gains (losses) | 180 | (14 | ) | (91 | ) | 260 | ||||||||||
Add: Net derivative gains (losses) | (3,174 | ) | (508 | ) | (2,725 | ) | 69 | |||||||||
Add: Other adjustments to continuing operations | 576 | (124 | ) | 374 | (392 | ) | ||||||||||
Add: Provision for income tax (expense) benefit | 844 | 221 | 836 | 16 | ||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | 3 | 3 | 6 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | (741 | ) | $ | 1,015 | $ | 364 | $ | 2,771 | |||||||
|
|
|
|
|
|
|
| |||||||||
Retail: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 575 | $ | 692 | $ | 1,161 | $ | 1,348 | ||||||||
Add: Total notable items | (391 | ) | (2 | ) | (445 | ) | (5 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 184 | 690 | 716 | 1,343 | ||||||||||||
Add: Net investment gains (losses) | 84 | 9 | (33 | ) | 77 | |||||||||||
Add: Net derivative gains (losses) | (3,643 | ) | (95 | ) | (3,654 | ) | 218 | |||||||||
Add: Other adjustments to continuing operations | 749 | (72 | ) | 717 | (264 | ) | ||||||||||
Add: Provision for income tax (expense) benefit | 984 | 55 | 1,040 | (11 | ) | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | (1,642 | ) | $ | 587 | $ | (1,214 | ) | $ | 1,363 | ||||||
|
|
|
|
|
|
|
| |||||||||
Group, Voluntary & Worksite Benefits: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 228 | $ | 229 | $ | 419 | $ | 469 | ||||||||
Add: Total notable items | (7 | ) | 2 | (24 | ) | (10 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 221 | 231 | 395 | 459 | ||||||||||||
Add: Net investment gains (losses) | 11 | 8 | (28 | ) | 11 | |||||||||||
Add: Net derivative gains (losses) | 314 | (264 | ) | 605 | (59 | ) | ||||||||||
Add: Other adjustments to continuing operations | (44 | ) | (41 | ) | (89 | ) | (83 | ) | ||||||||
Add: Provision for income tax (expense) benefit | (94 | ) | 104 | (166 | ) | 46 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 408 | $ | 38 | $ | 717 | $ | 374 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Corporate Benefit Funding: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 331 | $ | 406 | $ | 656 | $ | 775 | ||||||||
Add: Total notable items | (29 | ) | — | (59 | ) | — | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 302 | 406 | 597 | 775 | ||||||||||||
Add: Net investment gains (losses) | 67 | (31 | ) | (26 | ) | 174 | ||||||||||
Add: Net derivative gains (losses) | 181 | (134 | ) | 266 | (54 | ) | ||||||||||
Add: Other adjustments to continuing operations | (73 | ) | 13 | (148 | ) | (26 | ) | |||||||||
Add: Provision for income tax (expense) benefit | (61 | ) | 53 | (32 | ) | (33 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 416 | $ | 307 | $ | 657 | $ | 836 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Latin America: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 132 | $ | 116 | $ | 284 | $ | 248 | ||||||||
Add: Total notable items | (4 | ) | — | (19 | ) | (1 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 128 | 116 | 265 | 247 | ||||||||||||
Add: Net investment gains (losses) | 18 | — | (4 | ) | (2 | ) | ||||||||||
Add: Net derivative gains (losses) | (26 | ) | (15 | ) | 58 | (36 | ) | |||||||||
Add: Other adjustments to continuing operations | (56 | ) | (24 | ) | (106 | ) | (19 | ) | ||||||||
Add: Provision for income tax (expense) benefit | 15 | 9 | (6 | ) | 14 | |||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | 3 | 3 | 6 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 77 | $ | 83 | $ | 204 | $ | 198 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Asia: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 313 | $ | 364 | $ | 618 | $ | 691 | ||||||||
Add: Total notable items | (54 | ) | 61 | (54 | ) | 61 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 259 | 425 | 564 | 752 | ||||||||||||
Add: Net investment gains (losses) | 140 | 57 | 363 | 125 | ||||||||||||
Add: Net derivative gains (losses) | 606 | 9 | 1,017 | 27 | ||||||||||||
Add: Other adjustments to continuing operations | (30 | ) | (37 | ) | 37 | (92 | ) | |||||||||
Add: Provision for income tax (expense) benefit | (204 | ) | 111 | (347 | ) | 101 | ||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 1 | 1 | 1 | 1 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 770 | $ | 564 | $ | 1,633 | $ | 912 | ||||||||
|
|
|
|
|
|
|
| |||||||||
EMEA: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | 64 | $ | 50 | $ | 127 | $ | 120 | ||||||||
Add: Total notable items | — | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | 64 | 50 | 127 | 120 | ||||||||||||
Add: Net investment gains (losses) | 16 | 5 | 24 | 8 | ||||||||||||
Add: Net derivative gains (losses) | 3 | 13 | 2 | 14 | ||||||||||||
Add: Other adjustments to continuing operations | 48 | (12 | ) | 66 | 7 | |||||||||||
Add: Provision for income tax (expense) benefit | (35 | ) | 7 | (49 | ) | (19 | ) | |||||||||
Less: Net income (loss) attributable to noncontrolling interests | 1 | (1 | ) | 2 | 1 | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | 95 | $ | 64 | $ | 168 | $ | 129 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Corporate & Other: | ||||||||||||||||
Operating earnings available to common shareholders, adjusted for total notable items | $ | (233 | ) | $ | (153 | ) | $ | (405 | ) | $ | (293 | ) | ||||
Add: Total notable items | (1 | ) | — | (6 | ) | — | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating earnings available to common shareholders | (234 | ) | (153 | ) | (411 | ) | (293 | ) | ||||||||
Add: Net investment gains (losses) | (70 | ) | (181 | ) | (15 | ) | (240 | ) | ||||||||
Add: Net derivative gains (losses) | 466 | (426 | ) | 942 | (201 | ) | ||||||||||
Add: Other adjustments to continuing operations | (116 | ) | (4 | ) | (184 | ) | (10 | ) | ||||||||
Add: Provision for income tax (expense) benefit | (106 | ) | 206 | (238 | ) | 145 | ||||||||||
Less: Net income (loss) attributable to noncontrolling interests | — | 1 | — | 1 | ||||||||||||
Less: Preferred stock repurchase premium | — | 42 | — | 42 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) available to MetLife, Inc.’s common shareholders | $ | (60 | ) | $ | (601 | ) | $ | 94 | $ | (642 | ) | |||||
|
|
|
|
|
|
|
|
(1) | The impacts of asymmetrical and non-economic accounting for the three months ended June 30, 2016 are as follows: i) Net investment gains (losses) - $217 million; ii) Net derivative gains (losses) - $2.3 billion; iii) Policyholder benefits and claims and policyholder dividends - ($66) million; iv) Amortization of DAC and VOBA - $402 million; and v) Provision for income tax (expense) benefit - ($989) million. |
(2) | Operating earnings available to common shareholders is calculated on a stand alone basis and may not equal the sum of operating earnings available to common shareholders, adjusted for total notable items and total notable items. |
(3) | Book values exclude $2,066 million of equity related to preferred stock at both June 30, 2016 and 2015. |
(4) | Annualized using quarter-to-date results. |